维普中文期刊产品整合服务
30篇 您的检索式:作者名="Patruno R"
    题名 作者 年代 出处 被引量
1Vascular endo-thelial growth factor (VEGF) as a target of bevacizum-ab in cancer: from the biology to the clinic 显示文摘Ranieri G Patruno R Ruggieri E 2006CurrMed Chem2006,13,16:1
2Vascular endothelial growth factor concentrations in the plasma-activated platelets rich (P-APR) of healthy controls and colorectal cancer patients显示文摘Ranieri G Coviello M Patruno R 2004Oncol Rep2004,12,4:1
3VEGF concentration from plasma activated platelets rich correlates with microvascular density and grading in canine mast cell tumor spontaneous model 显示文摘Patruno R Arpaia N Gadaleta CD 2008J Cell Mol Med2008,13,3:1
4Vascular endothelial growth factor(VEGF) as a target of bevacizumab in cancer:from the biology to the clinic 显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chem2006,13,16:1
5Vascular endothelial growth factor ( VEGF ) as a target of bevacizumab in cancer: from the biology to the clinic显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Medchem2006,13,16:1
6Tlyptase- positive mast cells correlate with angiogenesis in early breast cancer patients显示文摘Ranieri G Ammendola M Patruno R 2009Int J Oncol2009,35,1:1
7Breast cancer tissuetryptase expression as a new possible antiangiogenic target显示文摘Ammendola M Misino A Patruno R 2011Breast2011,20,1:1
8Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic 显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chem2006,13,16:1
9Vascular endothelial growth factor(VEGF)as a target of bevacizumab in cancer:from the biology to the clinic显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chem2006,13,16:1
10Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer:from the biology to the clinic显示文摘Ranieri G Patruno R Ruggieri E 0,,16:1
11Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic 显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chem2006,13,16:1
12Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer 显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chern2006,13,16:1
13Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer:, from the biology to the clinic显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chem2006,13,16:1
14Do fisn thrombocytes play an immunological role? Their cytoenzymatic profiles and function during an accidental piscine candidiasis in aquarium显示文摘Passantino L Cianciotta A Patruno R 2005Immunopharmacology and Immunotoxicology2005,27,:1
15Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer:from the biology to the clinic 显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chem2006,13,16:1
16Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic 显示文摘Ranieri G Patruno R Ruggieri E 2006Curr Med Chem2006,13,16:1
17Vascular endothehal growth factor(VEGF) as a target of bevacizumab in cancer:from the biolo- gy to the clinic显示文摘Ranieri G Patruno R Ruggieri E 2006Curt Med Chem2006,13,:1
18VEGF concentration from plasma activated platelets rich correlates with microvascular densi- ty and grading in canine mast cell tumour spontaneous model显示文摘Patruno R Arpaia N Gadalet CD 2009Cell Mol Med2009,13,3:1
19Vaseular endothe- lial growth factor (VEGF) as a target of be bevacizumab in cancer: from the biology to the clinic 显示文摘Ranieri G Patruno R Ruqqieri E 2006Curr Med Chem2006,13,16:1
20Microvascular density and endothelial area correlate with Ki-67 proliferative rate in the canine non-HodgkinS lymphoma spontaneous model显示文摘Patruno R Zizzo N Zito A F 2006Leuk Lymphoma2006,47,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费